CXCL12 and non-small cell lung carcinoma: In order to assess this hypothesis, we performed Receiver Operating Characteristics (ROC) analysis in order to define optimal cut-off values for CXCL12 and CXCR4 immunoreactivities that could discriminate between NSCLC patients without and with brain metastasis [70].